Page last updated: 2024-08-21

erythromycin and erlotinib hydrochloride

erythromycin has been researched along with erlotinib hydrochloride in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barletta, E; Cusano, F; Ferrara, G; Ingordo, V1
Calvert, H; Fettner, S; Hamilton, M; Ling, J; Lum, BL; Pantze, M; Plummer, R; Rakhit, A; Ranson, M; Twelves, C1

Trials

1 trial(s) available for erythromycin and erlotinib hydrochloride

ArticleYear
Effect of erlotinib on CYP3A activity, evaluated in vitro and by dual probes in patients with cancer.
    Anti-cancer drugs, 2014, Volume: 25, Issue:7

    Topics: Adult; Aged; Antineoplastic Agents; Breath Tests; Cytochrome P-450 CYP3A; Drug Interactions; Erlotinib Hydrochloride; Erythromycin; Female; Humans; In Vitro Techniques; Male; Microsomes, Liver; Midazolam; Middle Aged; Neoplasms; Quinazolines

2014

Other Studies

1 other study(ies) available for erythromycin and erlotinib hydrochloride

ArticleYear
Erlotinib-induced pustular eruption.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009, Volume: 144, Issue:1

    Topics: Acneiform Eruptions; Administration, Cutaneous; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Erythromycin; Gels; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome

2009